Literature DB >> 19171417

Development of carcinoid tumour in hormonally treated adenocarcinoma of the prostate.

Joery P F Molenaar1, Anique Baten, Willeke A M Blokx, Arjen Hoogendam.   

Abstract

We present the case of an 81-yr-old man with a prostatic adenocarcinoma and a metastatic carcinoid. Simultaneous occurrence of hormonally treated adenocarcinoma of the prostate and a carcinoid has been described before. The pathogenesis of this coincidence is largely unclear; however, androgen deprivation therapy might play a key role in neuroendocrine differentiation of adenocarcinoma cells. Early recognition of the carcinoid syndrome is crucial, as surgical cure is not possible after metastasis. We provide a brief review of recent literature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171417     DOI: 10.1016/j.eururo.2009.01.019

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  Liver Metastases in Prostate Carcinoma Represent a Relatively Aggressive Subtype Refractory to Hormonal Therapy and Short-Duration Response to Docetaxel Monotherapy.

Authors:  Arsh Singh; Naga K S Cheedella; Shams A Shakil; Frederick Gulmi; Dong-Sung Kim; Jen C Wang
Journal:  World J Oncol       Date:  2015-02-14

2.  Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177Lu-PSMA-617 Radioligand Therapy.

Authors:  Robert Seifert; Konstantin Seitzer; Ken Herrmann; Katharina Kessel; Michael Schäfers; Jens Kleesiek; Matthias Weckesser; Martin Boegemann; Kambiz Rahbar
Journal:  Theranostics       Date:  2020-06-19       Impact factor: 11.556

3.  Prostate cancer with neuroendocrine differentiation--case report.

Authors:  G Glück; M Mihai; R Stoica; R Andrei; I Sinescu
Journal:  J Med Life       Date:  2012-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.